Xcout IntelModular Medical, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Modular Medical, Inc. among medical devices companies — ranked by similarity to what Modular Medical, Inc. actually does, not by market-cap band.
Subscribe to see Modular Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Modular Medical, Inc.
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
Modular Medical, Inc. at a glance
Modular Medical, Inc. is a medical devices company headquartered in San Diego, United States. It is publicly listed (MODD) with a market capitalisation of $25.4M. Xcout tracks 25 named people at Modular Medical, Inc., including James (Jeb) Besser (Chief Executive Officer).
Modular Medical, Inc. leadership
- James (Jeb) BesserChief Executive Officer
- James E. BesserChief Executive Officer
- Kevin SchmidChief Operating Officer
- James SullivanInterim Chief Financial Officer
- Paul DiPernaFounder, Chairman, President, Chief Financial Officer & Treasurer
- David BosshardHead of International Operations
19 more named people on record for Modular Medical, Inc., with roles, board committees and tenure — see the full roster →
Top 12 Modular Medical, Inc. competitors
Ranked by semantic similarity — how close each company is to Modular Medical, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Similar medical devices company
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.
Similar medical devices company
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Similar medical devices company
MicroTech Medical is a pioneer in the diabetes management medical devices industry, established in 2011 and located in the Hangzhou Future Sci-Tech City. The company specializes in the research, development, and manufacturing of diabetes glucose monitoring and treatment products.
Similar medical devices company
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
Similar medical devices company
Nugen Medical Devices Inc. develops and manufactures needle-free drug delivery systems, including the InsuJet needle-free insulin delivery system designed for diabetes management. The company serves patients globally by providing alternative medication administration technology in over 40 countries.
Medical Devices & Diabetes Care
Geffen Medical is an Israeli company that provides advanced diabetes management technologies, including the FreeStyle Libre and Omnipod systems.
Similar medical devices company
Morphic Medical develops medical device therapies designed to treat type 2 diabetes and obesity. Its flagship product, the RESET therapy, is an endoscopically delivered device intended to help reduce HbA1c and weight for patients who are underserved by medications and for whom surgery is not an option.
Biotechnology & Medical Devices
Molecular Matrix, Inc. is a privately held medical device and tissue regeneration company founded in 2011. Headquartered in Rancho Cordova, California, the company develops regenerative products.
Similar medical devices company
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Similar medical devices company
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Similar medical devices company
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Modular Medical, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Modular Medical, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →